180 Life Sciences Corp. Profile Avatar - Palmy Investing

180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor ne…

Biotechnology
US, Palo Alto [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ATNF's Analysis
CIK: 1690080 CUSIP: 68236V104 ISIN: US68236V3024 LEI: - UEI: -
Secondary Listings
ATNF has no secondary listings inside our databases.